source
- Endpoints 11 showcases top biotech startups, signaling renewed optimism and fundingThe Endpoints 11 awards highlight the most promising biotech startups of 2026, offering a snapshot of emerging trends in the sector. According to the summary, the awards illustrate that biotech ap…
- Jury awards Nektar $90 million in damages after lawsuit over broken rezpeg partnership with Eli LillyA jury in a US court has ordered Eli Lilly to pay Nektar Therapeutics $90 million after finding the pharma giant breached their collaboration on the experimental autoimmune drug rezpeg. Nektar and…